Revenue Growth

Advertisement

cGxPJobs Banner

Halozyme Reaffirms Long-Term Royalty Growth Despite Proposed Medicare Pricing Changes

SAN DIEGO, June 15, 2026 Halozyme Therapeutics, Inc. has confirmed that it expects zero to minimal impact on royalty...

By cGxPwire Editor
June 16, 2026

Read More

Novanta Acquires Riverpoint Medical in $1.45 Billion Deal

BOSTON, Massachusetts, USA – June 9, 2026 Novanta Inc. has announced a definitive agreement to acquire Riverpoint Medical in...

By cGxPwire Editor
June 10, 2026

Read More

Advertisement

cGxPJobs

Directory